Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...

Psoriasis and psoriatic arthritis are different diseases, but they are related. Some people may have both at the same time. Whether you're newly diagnosed with psoriasis or already in treatment ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

A recent study reaffirmed the safety and effectiveness of guselkumab, in managing psoriasis and psoriatic arthritis over an extended period of 208 weeks (approximately 4 years). This ...

You can apply sunscreen to psoriasis plaques to prevent sunburn, but, if the plaques from psoriasis are inflamed or cracked ...

Impact of Disease questionnaire (PsAID-12) scores were associated with treatment escalation, physicians primarily relied on ...

A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.